![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1623315 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of DACH1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1606339 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of DACH1 mRNA | CTD | PMID:20660070 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1623315 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1623315 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1623315 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DACH1 mRNA | CTD | PMID:24058054 | aflatoxin B1 | decreases methylation | ISO | RGD:1606339 | 6480464 | Aflatoxin B1 results in decreased methylation of DACH1 gene | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | RGD:1606339 | 6480464 | Aflatoxin B1 results in increased methylation of DACH1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RGD:1606339 | 6480464 | Tretinoin results in increased expression of DACH1 mRNA | CTD | PMID:23724009, PMID:33167477 | antirheumatic drug | increases expression | ISO | RGD:1606339 | 6480464 | Antirheumatic Agents results in increased expression of DACH1 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:1606339 | 6480464 | aristolochic acid I results in decreased expression of DACH1 mRNA | CTD | PMID:33212167 | atrazine | decreases expression | ISO | RGD:1606339 | 6480464 | Atrazine results in decreased expression of DACH1 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of DACH1 gene | CTD | PMID:28931070 | azoxystrobin | decreases expression | ISO | RGD:1606339 | 6480464 | azoxystrobin results in decreased expression of DACH1 mRNA | CTD | PMID:33512557 | benzo[a]pyrene | decreases expression | ISO | RGD:1623315 | 6480464 | Benzo(a)pyrene results in decreased expression of DACH1 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | increases methylation | ISO | RGD:1606339 | 6480464 | Benzo(a)pyrene results in increased methylation of DACH1 5' UTR, Benzo(a)pyrene results in increased methylation of DACH1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1606339 | 6480464 | Benzo(a)pyrene affects the methylation of DACH1 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases expression | ISO | RGD:1623315 | 6480464 | Benzo(a)pyrene results in increased expression of DACH1 mRNA | CTD | PMID:23735875 | benzo[b]fluoranthene | increases expression | ISO | RGD:1623315 | 6480464 | benzo(b)fluoranthene results in increased expression of DACH1 mRNA | CTD | PMID:26377693 | Benzo[k]fluoranthene | decreases expression | ISO | RGD:1623315 | 6480464 | benzo(k)fluoranthene results in decreased expression of DACH1 mRNA | CTD | PMID:26377693 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1606339 | 6480464 | Diethylhexyl Phthalate results in decreased expression of DACH1 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | ISO | RGD:1606339 | 6480464 | bisphenol A results in decreased expression of DACH1 mRNA | CTD | PMID:31715268 | bisphenol A | multiple interactions | ISO | RGD:1606339 | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of DACH1 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DACH1 mRNA | CTD | PMID:34947998 | carbon nanotube | increases expression | ISO | RGD:1623315 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloroprene | decreases expression | ISO | RGD:1623315 | 6480464 | Chloroprene results in decreased expression of DACH1 mRNA | CTD | PMID:23125180 | cisplatin | decreases expression | ISO | RGD:1606339 | 6480464 | Cisplatin results in decreased expression of DACH1 mRNA | CTD | PMID:27594783 | copper atom | multiple interactions | ISO | RGD:1606339 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DACH1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1606339 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DACH1 mRNA | CTD | PMID:20971185 | cyclosporin A | decreases expression | ISO | RGD:1606339 | 6480464 | Cyclosporine results in decreased expression of DACH1 mRNA | CTD | PMID:20106945, PMID:33631201 | DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of DACH1 mRNA | CTD | PMID:30207508 | diallyl trisulfide | increases expression | ISO | RGD:1606339 | 6480464 | diallyl trisulfide results in increased expression of DACH1 mRNA | CTD | PMID:27129776 | diallyl trisulfide | multiple interactions | ISO | RGD:1606339 | 6480464 | FOXQ1 protein inhibits the reaction [diallyl trisulfide results in increased expression of DACH1 mRNA] | CTD | PMID:27129776 | dibenz[a,h]anthracene | increases expression | ISO | RGD:1623315 | 6480464 | 1 more ... | CTD | PMID:26377693 | dorsomorphin | multiple interactions | ISO | RGD:1606339 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | multiple interactions | ISO | RGD:1606339 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DACH1 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | RGD:1606339 | 6480464 | entinostat results in decreased expression of DACH1 mRNA | CTD | PMID:26272509 | folic acid | decreases expression | ISO | RGD:1623315 | 6480464 | Folic Acid results in decreased expression of DACH1 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | RGD:1606339 | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of DACH1 gene | CTD | PMID:31601247 | methylmercury chloride | decreases expression | ISO | RGD:1606339 | 6480464 | methylmercuric chloride results in decreased expression of DACH1 mRNA | CTD | PMID:28001369 | mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1623315 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of DACH1 mRNA | CTD | PMID:22401849 | nickel atom | decreases expression | ISO | RGD:1606339 | 6480464 | Nickel results in decreased expression of DACH1 mRNA | CTD | PMID:24768652, PMID:25583101 | nickel dichloride | decreases expression | ISO | RGD:1606339 | 6480464 | nickel chloride results in decreased expression of DACH1 mRNA | CTD | PMID:17312168 | ozone | multiple interactions | ISO | RGD:1623315 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DACH1 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | RGD:1606339 | 6480464 | Acetaminophen affects the expression of DACH1 mRNA | CTD | PMID:25458485 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of DACH1 mRNA | CTD | PMID:30723492 | PCB138 | multiple interactions | ISO | RGD:1623315 | 6480464 | [2 more ... | CTD | PMID:25510870 | phenylmercury acetate | multiple interactions | ISO | RGD:1606339 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DACH1 mRNA | CTD | PMID:27188386 | potassium dichromate | increases expression | ISO | RGD:1623315 | 6480464 | Potassium Dichromate results in increased expression of DACH1 mRNA | CTD | PMID:23608068 | progesterone | multiple interactions | ISO | RGD:1606339 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of DACH1 mRNA | CTD | PMID:20660070 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of DACH1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | RGD:1606339 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | temozolomide | increases expression | ISO | RGD:1606339 | 6480464 | Temozolomide results in increased expression of DACH1 mRNA | CTD | PMID:31758290 | titanium dioxide | affects expression | ISO | RGD:1623315 | 6480464 | titanium dioxide affects the expression of DACH1 mRNA | CTD | PMID:23557971 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of DACH1 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:1606339 | 6480464 | trichostatin A results in increased expression of DACH1 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | ISO | RGD:1606339 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DACH1 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | RGD:1606339 | 6480464 | trichostatin A results in decreased expression of DACH1 mRNA | CTD | PMID:26272509 | tunicamycin | decreases expression | ISO | RGD:1606339 | 6480464 | Tunicamycin results in decreased expression of DACH1 mRNA | CTD | PMID:22378314 | valproic acid | decreases expression | ISO | RGD:1606339 | 6480464 | Valproic Acid results in decreased expression of DACH1 mRNA | CTD | PMID:23179753, PMID:28001369 | valproic acid | affects expression | ISO | RGD:1606339 | 6480464 | Valproic Acid affects the expression of DACH1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1606339 | 6480464 | Valproic Acid results in increased expression of DACH1 mRNA | CTD | PMID:24935251 | |